​

Jazz Pharmaceuticals Ownership | Who Owns Jazz Pharmaceuticals?

OverviewForecastRevenueFinancialsChartTranscripts

Jazz Pharmaceuticals Ownership Summary

Jazz Pharmaceuticals is owned by 96.27% institutional investors, 2.86% insiders, and 0.87% retail investors. Vanguard group is the largest institutional shareholder, holding 9.83% of JAZZ shares. Pacer US Cash Cows 100 ETF is the top mutual fund, with 3.55% of its assets in Jazz Pharmaceuticals shares.

JAZZ Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockJazz Pharmaceuticals96.27%2.86%0.87%
SectorHealthcare Stocks 279.42%10.64%-190.05%
IndustryBiotech Stocks 64.05%10.69%25.27%
IdeaCannabis Stocks List15.06%11.43%73.51%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group6.04M9.83%$743.36M
Blackrock6.15M9.83%$655.94M
Blackrock funding, inc. /de5.85M9.53%$720.58M
Lsv asset management2.53M4.12%$311.70M
Pacer advisors2.21M3.61%$272.71M
Dimensional fund advisors lp2.04M3.31%$250.62M
State street2.02M3.23%$215.31M
Capital world investors1.92M3.13%$236.86M
Ameriprise financial1.83M2.98%$225.08M
Ecor1 capital1.71M2.78%$210.15M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Estuary capital management lp232.52K8.37%$28.63M
Ecor1 capital1.71M7.95%$210.15M
Polaris capital management1.09M6.45%$133.72M
Krensavage asset management109.08K5.35%$11.64M
Sofinnova investments504.19K4.52%$62.09M
Gmt capital508.80K3.05%$62.66M
Avidity partners management lp234.50K2.84%$28.88M
Fairbanks capital management29.13K2.23%$3.59M
Centre asset management75.80K2.14%$9.34M
Graphene investments sas24.20K2.06%$2.98M

Top Buyers

HolderShares% AssetsChange
Fuller & thaler asset management939.35K0.44%507.23K
Dimensional fund advisors lp2.04M0.06%320.72K
Sofinnova investments504.19K4.52%315.63K
Ameriprise financial1.83M0.06%315.61K
Gmt capital508.80K3.05%296.80K

Top Sellers

HolderShares% AssetsChange
Baupost group llc/ma---1.27M
Camber capital management lp---1.15M
Vestal point capital, lp---975.00K
Blackrock6.15M0.01%-924.16K
Rubric capital management lp---616.62K

New Positions

HolderShares% AssetsChangeValue
Raymond james financial92.35K0.00%92.35K$11.37M
Centre asset management75.80K2.14%75.80K$9.34M
Mcgowan group asset management48.99K0.81%48.99K$6.03M
Lmcg investments45.46K0.34%45.46K$5.60M
O'shaughnessy asset management44.82K0.05%44.82K$5.52M

Sold Out

HolderChange
Harbor investment advisory-1.00
Psi advisors-1.00
Center for financial planning-1.00
Rfp financial group-2.00
Financial gravity asset management-2.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20255528.02%58,706,955-0.60%961.04%31219.54%155-7.74%
Dec 31, 2024468-2.50%56,158,556-2.64%911.04%238-155-1.27%
Sep 30, 20244732.83%57,472,0080.00%931.12%2357.31%155-6.06%
Jun 30, 2024456-6.37%57,467,965-0.65%911.10%218-6.84%1620.62%
Mar 31, 2024487-4.32%57,846,6723.04%911.16%234-0.85%161-10.56%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Pacer US Cash Cows 100 ETF2.16M3.55%3.19K
iShares Core S&P Mid-Cap ETF2.01M3.31%-3.63K
Capital Group Fundamental Invtrs Comp2.00M3.31%105.19K
American Funds Fundamental Invs A2.00M3.31%105.19K
Vanguard Total Stock Mkt Idx Inv1.89M3.12%38.47K
Vanguard US Total Market Shares ETF1.84M3.03%-44.10K
Vanguard Small Cap Index1.43M2.36%-24.25K
FullerThaler Behavioral Small-Cap Equity1.27M2.09%369.80K
FullerThaler Behavioral Sm-Cp Eq R61.27M2.06%369.80K
Vanguard Institutional Extnd Mkt Idx Tr950.23K1.57%8.51K

Recent Insider Transactions

DateNameRoleActivityValue
Aug 01, 2025COZADD BRUCE C Chairman & CEOSell$113.21K
Jul 01, 2025COZADD BRUCE C Chairman & CEOSell$52.63K
Jul 01, 2025COZADD BRUCE C Chairman & CEOSell$55.00K
Jun 03, 2025COZADD BRUCE C Chairman & CEOSell$55.00K
Jun 02, 2025COZADD BRUCE C Chairman & CEOSell$53.95K

Insider Transactions Trends

DateBuySell
2025 Q3-3
2025 Q245
2025 Q1-10
2024 Q4-4
2024 Q3-1

JAZZ Ownership FAQ

Who Owns Jazz Pharmaceuticals?

Jazz Pharmaceuticals shareholders are primarily institutional investors at 96.27%, followed by 2.86% insiders and 0.87% retail investors. The average institutional ownership in Jazz Pharmaceuticals's industry, Biotech Stocks , is 64.05%, which Jazz Pharmaceuticals exceeds.

Who owns the most shares of Jazz Pharmaceuticals?

Jazz Pharmaceuticals’s largest shareholders are Vanguard group (6.04M shares, 9.83%), Blackrock (6.15M shares, 9.83%), and Blackrock funding, inc. /de (5.85M shares, 9.53%). Together, they hold 29.18% of Jazz Pharmaceuticals’s total shares outstanding.

Does Blackrock own Jazz Pharmaceuticals?

Yes, BlackRock owns 9.83% of Jazz Pharmaceuticals, totaling 6.15M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 655.94M$. In the last quarter, BlackRock decreased its holdings by -924K shares, a -13.07% change.

Who is Jazz Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Estuary capital management lp is Jazz Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 8.37% of its assets in 232.52K Jazz Pharmaceuticals shares, valued at 28.63M$.

Who is the top mutual fund holder of Jazz Pharmaceuticals shares?

Pacer US Cash Cows 100 ETF is the top mutual fund holder of Jazz Pharmaceuticals shares, with 3.55% of its total shares outstanding invested in 2.16M Jazz Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools